Status:
COMPLETED
Lymphoedema Among Persons With Head- and Neck Cancer
Lead Sponsor:
Lund University
Collaborating Sponsors:
Skane University Hospital
Conditions:
Cancer of Head and Neck
Eligibility:
All Genders
18+ years
Brief Summary
Lymphedema in the head and neck area is common after treatment for head and neck cancer. The aim of the research project is: • to assess the prevalence of lymphedema in patients with head and neck c...
Detailed Description
Measurement of tissue water is performed with a device (MoistureMeterD) see appendix 1. In addition, the neck circumference will be assessed with a measuring tape, according to Purcell (9), see append...
Eligibility Criteria
Inclusion
- Biopsy or cytology confirmed HNC (all malignant types are accepted) from the oropharynx (OPC), oral cavity (OC) or neck metastases from unknown primary cancer of the head and neck (CUP).
- Tumour stage T1-4, N0-3.
- Planned for treatment with curative intent as recommended at the multidisciplinary tumour board.
- Age \>18 years. Able to give informed consent
Exclusion
- Previous treatment of HNC or radiation to the head and neck area.
- Planned surgery that includes free tissue transfer or pedicled flaps in the neck (local facial pedicled flaps are accepted).
- Planned neck dissection involving less than three regions of the neck.
- Planned proton therapy.
- Pre-treatment surgery or Botox injections in the tissue in the head and neck area.
- Pregnancy
Key Trial Info
Start Date :
October 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 4 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05316974
Start Date
October 1 2022
End Date
April 4 2025
Last Update
October 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ENT department Skane University Hospital
Lund, Sweden, 22100